Synapsa (Bacopa monnieri)

Bacopa monnieri (Synapsa standardized extract) is a bioactive-rich botanical rather than a macronutrient source. Primary bioactive compounds include bacosides A and B (standardized to 45-55% in Synapsa extract), which are triterpenoid saponins responsible for cognitive effects. Bacoside A comprises bacoside A3, bacopasaponin C, and bacosides A1/A2. Additional saponins include bacopasaponins D, E, and F at trace concentrations. Alkaloids present include brahmine (~0.003% dry weight), herpestine, and nicotine at negligible levels (<0.001%). Flavonoids include luteolin (~0.1-0.5 mg/g dry extract) and apigenin (~0.05-0.2 mg/g). Phytosterols such as beta-sitosterol and stigmasterol are present at approximately 0.1-0.3% of dry weight. Contains betulinic acid (~0.1-0.2% dry weight) contributing antioxidant activity. Protein content is minimal (<5% dry weight), consisting primarily of structural plant proteins with low bioavailability. Carbohydrates account for approximately 40-50% of dry weight, largely as polysaccharides and glycosides. Fat content is negligible (<2% dry weight). Micronutrients include trace amounts of calcium (~50-80 mg/100g dry herb), iron (~3-5 mg/100g), and zinc (~1-2 mg/100g). Bioavailability is enhanced when taken with fats due to saponin lipophilicity; Synapsa's patented processing improves bacoside bioavailability by approximately 20-30% compared to raw extract. Typical effective dose of Synapsa extract is 300-450 mg/day standardized to bacosides.